APO Research

APO RESEARCH · REPORT

Prothrombin Complex Concentrate(PCC)

Selected research

Market Structure

Global Prothrombin Complex Concentrate(PCC) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Prothrombin Complex Concentrate(PCC) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Prothrombin Complex Concentrate(PCC) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Prothrombin Complex Concentrate(PCC) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prothrombin Complex Concentrate(PCC) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Prothrombin Complex Concentrate(PCC) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Prothrombin Complex Concentrate(PCC) include CSL, WEIGUANG BIOLOGICAL, Taibang Biologic Group, SHANGHAI RAAS, Green Cross, Jiangxi Boya Bio-Pharmaceutical, HUALAN BIOLOGICAL ENGINEERING, Guangdong Shuanglin Biopharmaceutical and Beijing Tiantan Biological Products, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Prothrombin Complex Concentrate(PCC) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Prothrombin Complex Concentrate(PCC) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Prothrombin Complex Concentrate(PCC) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Prothrombin Complex Concentrate(PCC) market size, projected growth trends, production technologies, key applications, and end-use industries.

Prothrombin Complex Concentrate(PCC) Segment by Company

CSL

WEIGUANG BIOLOGICAL

Taibang Biologic Group

SHANGHAI RAAS

Green Cross

Jiangxi Boya Bio-Pharmaceutical

HUALAN BIOLOGICAL ENGINEERING

Guangdong Shuanglin Biopharmaceutical

Beijing Tiantan Biological Products

BOHUI

Biotest

Prothrombin Complex Concentrate(PCC) Segment by Type

1000IU

100IU

200IU

300IU

400IU

Prothrombin Complex Concentrate(PCC) Segment by Application

Hopistial

Clinic

Others

Prothrombin Complex Concentrate(PCC) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prothrombin Complex Concentrate(PCC) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prothrombin Complex Concentrate(PCC) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prothrombin Complex Concentrate(PCC).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Prothrombin Complex Concentrate(PCC) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Prothrombin Complex Concentrate(PCC) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Prothrombin Complex Concentrate(PCC) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Prothrombin Complex Concentrate(PCC) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Prothrombin Complex Concentrate(PCC) Industry Trends Table 2. Prothrombin Complex Concentrate(PCC) Industry Drivers Table 3. Prothrombin Complex Concentrate(PCC) Industry Opportunities and Challenges Table 4. Prothrombin Complex Concentrate(PCC) Industry Restraints Table 5. Global Prothrombin Complex Concentrate(PCC) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Prothrombin Complex Concentrate(PCC) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Prothrombin Complex Concentrate(PCC) Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Manufacturers Table 9. Global Prothrombin Complex Concentrate(PCC) Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Prothrombin Complex Concentrate(PCC) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Prothrombin Complex Concentrate(PCC) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Prothrombin Complex Concentrate(PCC) Manufacturers, Product Type & Application Table 13. Global Prothrombin Complex Concentrate(PCC) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Prothrombin Complex Concentrate(PCC) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 1000IU Table 17. Major Manufacturers of 100IU Table 18. Major Manufacturers of 200IU Table 19. Major Manufacturers of 300IU Table 20. Major Manufacturers of 400IU Table 21. Global Prothrombin Complex Concentrate(PCC) Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Prothrombin Complex Concentrate(PCC) Sales by Type (2021-2026) & (K Units) Table 23. Global Prothrombin Complex Concentrate(PCC) Sales by Type (2027-2032) & (K Units) Table 24. Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Type (2021-2026) Table 25. Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Type (2027-2032) Table 26. Global Prothrombin Complex Concentrate(PCC) Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Prothrombin Complex Concentrate(PCC) Revenue by Type (2021-2026) & (K Units) Table 28. Global Prothrombin Complex Concentrate(PCC) Revenue by Type (2027-2032) & (K Units) Table 29. Global Prothrombin Complex Concentrate(PCC) Revenue Market Share by Type (2021-2026) Table 30. Global Prothrombin Complex Concentrate(PCC) Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Hopistial Table 32. Major Manufacturers of Clinic Table 33. Major Manufacturers of Others Table 34. Global Prothrombin Complex Concentrate(PCC) Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Prothrombin Complex Concentrate(PCC) Sales by Application (2021-2026) & (K Units) Table 36. Global Prothrombin Complex Concentrate(PCC) Sales by Application (2027-2032) & (K Units) Table 37. Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Application (2021-2026) Table 38. Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Application (2027-2032) Table 39. Global Prothrombin Complex Concentrate(PCC) Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Prothrombin Complex Concentrate(PCC) Revenue by Application (2021-2026) & (K Units) Table 41. Global Prothrombin Complex Concentrate(PCC) Revenue by Application (2027-2032) & (K Units) Table 42. Global Prothrombin Complex Concentrate(PCC) Revenue Market Share by Application (2021-2026) Table 43. Global Prothrombin Complex Concentrate(PCC) Revenue Market Share by Application (2027-2032) Table 44. Global Prothrombin Complex Concentrate(PCC) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Prothrombin Complex Concentrate(PCC) Sales by Region (2021-2026) & (K Units) Table 46. Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Region (2021-2026) Table 47. Global Prothrombin Complex Concentrate(PCC) Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global Prothrombin Complex Concentrate(PCC) Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Prothrombin Complex Concentrate(PCC) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America Prothrombin Complex Concentrate(PCC) Sales by Country (2021-2026) & (K Units) Table 51. North America Prothrombin Complex Concentrate(PCC) Sales by Country (2027-2032) & (K Units) Table 52. Europe Prothrombin Complex Concentrate(PCC) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe Prothrombin Complex Concentrate(PCC) Sales by Country (2021-2026) & (K Units) Table 54. Europe Prothrombin Complex Concentrate(PCC) Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Prothrombin Complex Concentrate(PCC) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific Prothrombin Complex Concentrate(PCC) Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific Prothrombin Complex Concentrate(PCC) Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa Prothrombin Complex Concentrate(PCC) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa Prothrombin Complex Concentrate(PCC) Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa Prothrombin Complex Concentrate(PCC) Sales by Country (2027-2032) & (K Units) Table 61. Global Prothrombin Complex Concentrate(PCC) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Prothrombin Complex Concentrate(PCC) Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Prothrombin Complex Concentrate(PCC) Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Prothrombin Complex Concentrate(PCC) Revenue Market Share by Region (2021-2026) Table 65. Global Prothrombin Complex Concentrate(PCC) Revenue Market Share by Region (2027-2032) Table 66. CSL Company Information Table 67. CSL Business Overview Table 68. CSL Prothrombin Complex Concentrate(PCC) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. CSL Prothrombin Complex Concentrate(PCC) Product Portfolio Table 70. CSL Recent Development Table 71. WEIGUANG BIOLOGICAL Company Information Table 72. WEIGUANG BIOLOGICAL Business Overview Table 73. WEIGUANG BIOLOGICAL Prothrombin Complex Concentrate(PCC) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. WEIGUANG BIOLOGICAL Prothrombin Complex Concentrate(PCC) Product Portfolio Table 75. WEIGUANG BIOLOGICAL Recent Development Table 76. Taibang Biologic Group Company Information Table 77. Taibang Biologic Group Business Overview Table 78. Taibang Biologic Group Prothrombin Complex Concentrate(PCC) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Taibang Biologic Group Prothrombin Complex Concentrate(PCC) Product Portfolio Table 80. Taibang Biologic Group Recent Development Table 81. SHANGHAI RAAS Company Information Table 82. SHANGHAI RAAS Business Overview Table 83. SHANGHAI RAAS Prothrombin Complex Concentrate(PCC) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. SHANGHAI RAAS Prothrombin Complex Concentrate(PCC) Product Portfolio Table 85. SHANGHAI RAAS Recent Development Table 86. Green Cross Company Information Table 87. Green Cross Business Overview Table 88. Green Cross Prothrombin Complex Concentrate(PCC) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Green Cross Prothrombin Complex Concentrate(PCC) Product Portfolio Table 90. Green Cross Recent Development Table 91. Jiangxi Boya Bio-Pharmaceutical Company Information Table 92. Jiangxi Boya Bio-Pharmaceutical Business Overview Table 93. Jiangxi Boya Bio-Pharmaceutical Prothrombin Complex Concentrate(PCC) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Jiangxi Boya Bio-Pharmaceutical Prothrombin Complex Concentrate(PCC) Product Portfolio Table 95. Jiangxi Boya Bio-Pharmaceutical Recent Development Table 96. HUALAN BIOLOGICAL ENGINEERING Company Information Table 97. HUALAN BIOLOGICAL ENGINEERING Business Overview Table 98. HUALAN BIOLOGICAL ENGINEERING Prothrombin Complex Concentrate(PCC) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. HUALAN BIOLOGICAL ENGINEERING Prothrombin Complex Concentrate(PCC) Product Portfolio Table 100. HUALAN BIOLOGICAL ENGINEERING Recent Development Table 101. Guangdong Shuanglin Biopharmaceutical Company Information Table 102. Guangdong Shuanglin Biopharmaceutical Business Overview Table 103. Guangdong Shuanglin Biopharmaceutical Prothrombin Complex Concentrate(PCC) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Guangdong Shuanglin Biopharmaceutical Prothrombin Complex Concentrate(PCC) Product Portfolio Table 105. Guangdong Shuanglin Biopharmaceutical Recent Development Table 106. Beijing Tiantan Biological Products Company Information Table 107. Beijing Tiantan Biological Products Business Overview Table 108. Beijing Tiantan Biological Products Prothrombin Complex Concentrate(PCC) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Beijing Tiantan Biological Products Prothrombin Complex Concentrate(PCC) Product Portfolio Table 110. Beijing Tiantan Biological Products Recent Development Table 111. BOHUI Company Information Table 112. BOHUI Business Overview Table 113. BOHUI Prothrombin Complex Concentrate(PCC) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. BOHUI Prothrombin Complex Concentrate(PCC) Product Portfolio Table 115. BOHUI Recent Development Table 116. Biotest Company Information Table 117. Biotest Business Overview Table 118. Biotest Prothrombin Complex Concentrate(PCC) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Biotest Prothrombin Complex Concentrate(PCC) Product Portfolio Table 120. Biotest Recent Development Table 121. Key Raw Materials Table 122. Raw Materials Key Suppliers Table 123. Prothrombin Complex Concentrate(PCC) Distributors List Table 124. Prothrombin Complex Concentrate(PCC) Customers List Table 125. Research Programs/Design for This Report Table 126. Authors List of This Report Table 127. Secondary Sources Table 128. Primary Sources List of Figures Figure 1. Prothrombin Complex Concentrate(PCC) Product Image Figure 2. Global Prothrombin Complex Concentrate(PCC) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prothrombin Complex Concentrate(PCC) Market Size (2021-2032) & (US$ Million) Figure 4. Global Prothrombin Complex Concentrate(PCC) Sales (2021-2032) & (K Units) Figure 5. Global Prothrombin Complex Concentrate(PCC) Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Prothrombin Complex Concentrate(PCC) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 1000IU Image Figure 9. 100IU Image Figure 10. 200IU Image Figure 11. 300IU Image Figure 12. 400IU Image Figure 13. Global Prothrombin Complex Concentrate(PCC) Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Prothrombin Complex Concentrate(PCC) Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Type (2021-2032) Figure 16. Global Prothrombin Complex Concentrate(PCC) Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Prothrombin Complex Concentrate(PCC) Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Prothrombin Complex Concentrate(PCC) Revenue Market Share by Type (2021-2032) Figure 19. Hopistial Image Figure 20. Clinic Image Figure 21. Others Image Figure 22. Global Prothrombin Complex Concentrate(PCC) Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Prothrombin Complex Concentrate(PCC) Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Application (2021-2032) Figure 25. Global Prothrombin Complex Concentrate(PCC) Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Prothrombin Complex Concentrate(PCC) Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Prothrombin Complex Concentrate(PCC) Revenue Market Share by Application (2021-2032) Figure 28. North America Prothrombin Complex Concentrate(PCC) Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America Prothrombin Complex Concentrate(PCC) Sales Market Share by Country (2021-2032) Figure 30. U.S. Prothrombin Complex Concentrate(PCC) Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada Prothrombin Complex Concentrate(PCC) Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico Prothrombin Complex Concentrate(PCC) Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Prothrombin Complex Concentrate(PCC) Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Prothrombin Complex Concentrate(PCC) Sales Market Share by Country (2021-2032) Figure 35. Germany Prothrombin Complex Concentrate(PCC) Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France Prothrombin Complex Concentrate(PCC) Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. Prothrombin Complex Concentrate(PCC) Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy Prothrombin Complex Concentrate(PCC) Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands Prothrombin Complex Concentrate(PCC) Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Prothrombin Complex Concentrate(PCC) Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Prothrombin Complex Concentrate(PCC) Sales Market Share by Country (2021-2032) Figure 42. China Prothrombin Complex Concentrate(PCC) Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan Prothrombin Complex Concentrate(PCC) Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea Prothrombin Complex Concentrate(PCC) Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia Prothrombin Complex Concentrate(PCC) Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India Prothrombin Complex Concentrate(PCC) Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia Prothrombin Complex Concentrate(PCC) Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Prothrombin Complex Concentrate(PCC) Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Prothrombin Complex Concentrate(PCC) Sales Market Share by Country (2021-2032) Figure 50. Brazil Prothrombin Complex Concentrate(PCC) Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa Prothrombin Complex Concentrate(PCC) Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia Prothrombin Complex Concentrate(PCC) Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey Prothrombin Complex Concentrate(PCC) Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina Prothrombin Complex Concentrate(PCC) Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE Prothrombin Complex Concentrate(PCC) Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt Prothrombin Complex Concentrate(PCC) Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile Prothrombin Complex Concentrate(PCC) Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global Prothrombin Complex Concentrate(PCC) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Prothrombin Complex Concentrate(PCC) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Prothrombin Complex Concentrate(PCC) Revenue (2021-2032) & (US$ Million) Figure 61. North America Prothrombin Complex Concentrate(PCC) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Prothrombin Complex Concentrate(PCC) Revenue (2021-2032) & (US$ Million) Figure 63. Europe Prothrombin Complex Concentrate(PCC) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Prothrombin Complex Concentrate(PCC) Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Prothrombin Complex Concentrate(PCC) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Prothrombin Complex Concentrate(PCC) Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Prothrombin Complex Concentrate(PCC) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Prothrombin Complex Concentrate(PCC) Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Prothrombin Complex Concentrate(PCC) Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 1000IU
  • 100IU
  • 200IU
  • 300IU
  • 400IU
Applications
  • Hopistial
  • Clinic
  • Others
Companies covered
  • CSL
  • WEIGUANG BIOLOGICAL
  • Taibang Biologic Group
  • SHANGHAI RAAS
  • Green Cross
  • Jiangxi Boya Bio-Pharmaceutical
  • HUALAN BIOLOGICAL ENGINEERING
  • Guangdong Shuanglin Biopharmaceutical
  • Beijing Tiantan Biological Products
  • BOHUI
  • Biotest

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Prothrombin Complex Concentrate(PCC) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Prothrombin Complex Concentrate(PCC) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Prothrombin Complex Concentrate(PCC) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Prothrombin Complex Concentrate(PCC) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Prothrombin Complex Concentrate(PCC) Market Dynamics
  1. 2.1 Prothrombin Complex Concentrate(PCC) Industry Trends
  2. 2.2 Prothrombin Complex Concentrate(PCC) Industry Drivers
  3. 2.3 Prothrombin Complex Concentrate(PCC) Industry Opportunities and Challenges
  4. 2.4 Prothrombin Complex Concentrate(PCC) Industry Restraints
3 Prothrombin Complex Concentrate(PCC) Market by Manufacturers
  1. 3.1 Global Prothrombin Complex Concentrate(PCC) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Prothrombin Complex Concentrate(PCC) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Prothrombin Complex Concentrate(PCC) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Prothrombin Complex Concentrate(PCC) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Prothrombin Complex Concentrate(PCC) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Prothrombin Complex Concentrate(PCC) Manufacturers, Product Type & Application
  7. 3.7 Global Prothrombin Complex Concentrate(PCC) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Prothrombin Complex Concentrate(PCC) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Prothrombin Complex Concentrate(PCC) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Prothrombin Complex Concentrate(PCC) Tier 1, Tier 2, and Tier 3
4 Prothrombin Complex Concentrate(PCC) Market by Type
  1. 4.1 Prothrombin Complex Concentrate(PCC) Type Introduction
  2. 4.1.1 1000IU
  3. 4.1.2 100IU
  4. 4.1.3 200IU
  5. 4.1.4 300IU
  6. 4.1.5 400IU
  7. 4.2 Global Prothrombin Complex Concentrate(PCC) Sales by Type
  8. 4.2.1 Global Prothrombin Complex Concentrate(PCC) Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Prothrombin Complex Concentrate(PCC) Sales by Type (2021-2032)
  10. 4.2.3 Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Type (2021-2032)
  11. 4.3 Global Prothrombin Complex Concentrate(PCC) Revenue by Type
  12. 4.3.1 Global Prothrombin Complex Concentrate(PCC) Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Prothrombin Complex Concentrate(PCC) Revenue by Type (2021-2032)
  14. 4.3.3 Global Prothrombin Complex Concentrate(PCC) Revenue Market Share by Type (2021-2032)
5 Prothrombin Complex Concentrate(PCC) Market by Application
  1. 5.1 Prothrombin Complex Concentrate(PCC) Application Introduction
  2. 5.1.1 Hopistial
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Prothrombin Complex Concentrate(PCC) Sales by Application
  6. 5.2.1 Global Prothrombin Complex Concentrate(PCC) Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Prothrombin Complex Concentrate(PCC) Sales by Application (2021-2032)
  8. 5.2.3 Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Application (2021-2032)
  9. 5.3 Global Prothrombin Complex Concentrate(PCC) Revenue by Application
  10. 5.3.1 Global Prothrombin Complex Concentrate(PCC) Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Prothrombin Complex Concentrate(PCC) Revenue by Application (2021-2032)
  12. 5.3.3 Global Prothrombin Complex Concentrate(PCC) Revenue Market Share by Application (2021-2032)
6 Global Prothrombin Complex Concentrate(PCC) Sales by Region
  1. 6.1 Global Prothrombin Complex Concentrate(PCC) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Prothrombin Complex Concentrate(PCC) Sales by Region (2021-2032)
  3. 6.2.1 Global Prothrombin Complex Concentrate(PCC) Sales by Region (2021-2026)
  4. 6.2.2 Global Prothrombin Complex Concentrate(PCC) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Prothrombin Complex Concentrate(PCC) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Prothrombin Complex Concentrate(PCC) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Prothrombin Complex Concentrate(PCC) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Prothrombin Complex Concentrate(PCC) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Prothrombin Complex Concentrate(PCC) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Prothrombin Complex Concentrate(PCC) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Prothrombin Complex Concentrate(PCC) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Prothrombin Complex Concentrate(PCC) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Prothrombin Complex Concentrate(PCC) Revenue by Region
  1. 7.1 Global Prothrombin Complex Concentrate(PCC) Revenue by Region
  2. 7.1.1 Global Prothrombin Complex Concentrate(PCC) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Prothrombin Complex Concentrate(PCC) Revenue by Region (2021-2026)
  4. 7.1.3 Global Prothrombin Complex Concentrate(PCC) Revenue by Region (2027-2032)
  5. 7.1.4 Global Prothrombin Complex Concentrate(PCC) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Prothrombin Complex Concentrate(PCC) Revenue (2021-2032)
  8. 7.2.2 North America Prothrombin Complex Concentrate(PCC) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Prothrombin Complex Concentrate(PCC) Revenue (2021-2032)
  11. 7.3.2 Europe Prothrombin Complex Concentrate(PCC) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Prothrombin Complex Concentrate(PCC) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Prothrombin Complex Concentrate(PCC) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Prothrombin Complex Concentrate(PCC) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Prothrombin Complex Concentrate(PCC) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 CSL
  2. 8.1.1 CSL Company Information
  3. 8.1.2 CSL Business Overview
  4. 8.1.3 CSL Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 CSL Prothrombin Complex Concentrate(PCC) Product Portfolio
  6. 8.1.5 CSL Recent Developments
  7. 8.2 WEIGUANG BIOLOGICAL
  8. 8.2.1 WEIGUANG BIOLOGICAL Company Information
  9. 8.2.2 WEIGUANG BIOLOGICAL Business Overview
  10. 8.2.3 WEIGUANG BIOLOGICAL Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 WEIGUANG BIOLOGICAL Prothrombin Complex Concentrate(PCC) Product Portfolio
  12. 8.2.5 WEIGUANG BIOLOGICAL Recent Developments
  13. 8.3 Taibang Biologic Group
  14. 8.3.1 Taibang Biologic Group Company Information
  15. 8.3.2 Taibang Biologic Group Business Overview
  16. 8.3.3 Taibang Biologic Group Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Taibang Biologic Group Prothrombin Complex Concentrate(PCC) Product Portfolio
  18. 8.3.5 Taibang Biologic Group Recent Developments
  19. 8.4 SHANGHAI RAAS
  20. 8.4.1 SHANGHAI RAAS Company Information
  21. 8.4.2 SHANGHAI RAAS Business Overview
  22. 8.4.3 SHANGHAI RAAS Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 SHANGHAI RAAS Prothrombin Complex Concentrate(PCC) Product Portfolio
  24. 8.4.5 SHANGHAI RAAS Recent Developments
  25. 8.5 Green Cross
  26. 8.5.1 Green Cross Company Information
  27. 8.5.2 Green Cross Business Overview
  28. 8.5.3 Green Cross Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Green Cross Prothrombin Complex Concentrate(PCC) Product Portfolio
  30. 8.5.5 Green Cross Recent Developments
  31. 8.6 Jiangxi Boya Bio-Pharmaceutical
  32. 8.6.1 Jiangxi Boya Bio-Pharmaceutical Company Information
  33. 8.6.2 Jiangxi Boya Bio-Pharmaceutical Business Overview
  34. 8.6.3 Jiangxi Boya Bio-Pharmaceutical Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Jiangxi Boya Bio-Pharmaceutical Prothrombin Complex Concentrate(PCC) Product Portfolio
  36. 8.6.5 Jiangxi Boya Bio-Pharmaceutical Recent Developments
  37. 8.7 HUALAN BIOLOGICAL ENGINEERING
  38. 8.7.1 HUALAN BIOLOGICAL ENGINEERING Company Information
  39. 8.7.2 HUALAN BIOLOGICAL ENGINEERING Business Overview
  40. 8.7.3 HUALAN BIOLOGICAL ENGINEERING Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 HUALAN BIOLOGICAL ENGINEERING Prothrombin Complex Concentrate(PCC) Product Portfolio
  42. 8.7.5 HUALAN BIOLOGICAL ENGINEERING Recent Developments
  43. 8.8 Guangdong Shuanglin Biopharmaceutical
  44. 8.8.1 Guangdong Shuanglin Biopharmaceutical Company Information
  45. 8.8.2 Guangdong Shuanglin Biopharmaceutical Business Overview
  46. 8.8.3 Guangdong Shuanglin Biopharmaceutical Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Guangdong Shuanglin Biopharmaceutical Prothrombin Complex Concentrate(PCC) Product Portfolio
  48. 8.8.5 Guangdong Shuanglin Biopharmaceutical Recent Developments
  49. 8.9 Beijing Tiantan Biological Products
  50. 8.9.1 Beijing Tiantan Biological Products Company Information
  51. 8.9.2 Beijing Tiantan Biological Products Business Overview
  52. 8.9.3 Beijing Tiantan Biological Products Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Beijing Tiantan Biological Products Prothrombin Complex Concentrate(PCC) Product Portfolio
  54. 8.9.5 Beijing Tiantan Biological Products Recent Developments
  55. 8.10 BOHUI
  56. 8.10.1 BOHUI Company Information
  57. 8.10.2 BOHUI Business Overview
  58. 8.10.3 BOHUI Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 BOHUI Prothrombin Complex Concentrate(PCC) Product Portfolio
  60. 8.10.5 BOHUI Recent Developments
  61. 8.11 Biotest
  62. 8.11.1 Biotest Company Information
  63. 8.11.2 Biotest Business Overview
  64. 8.11.3 Biotest Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Biotest Prothrombin Complex Concentrate(PCC) Product Portfolio
  66. 8.11.5 Biotest Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Prothrombin Complex Concentrate(PCC) Value Chain Analysis
  2. 9.1.1 Prothrombin Complex Concentrate(PCC) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Prothrombin Complex Concentrate(PCC) Production Mode & Process
  6. 9.2 Prothrombin Complex Concentrate(PCC) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Prothrombin Complex Concentrate(PCC) Distributors
  9. 9.2.3 Prothrombin Complex Concentrate(PCC) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research